TCM
Traynor Capital Management’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.1M | Buy |
55,594
+656
| +1% | +$509K | 3.06% | 6 |
|
|
2025
Q1 | $45.4M | Buy |
54,938
+3,907
| +8% | +$3.23M | 3.82% | 6 |
|
|
2024
Q4 | $39.4M | Buy |
51,031
+2,999
| +6% | +$2.32M | 2.63% | 6 |
|
|
2024
Q3 | $42.6M | Buy |
48,032
+5,375
| +13% | +$4.76M | 2.55% | 6 |
|
|
2024
Q2 | $38.6M | Buy |
42,657
+11,824
| +38% | +$10.7M | 2.89% | 7 |
|
|
2024
Q1 | $24M | Buy |
30,833
+8,563
| +38% | +$6.66M | 2.08% | 8 |
|
|
2023
Q4 | $13M | Buy |
22,270
+5,212
| +31% | +$3.04M | 1.33% | 12 |
|
|
2023
Q3 | $9.16M | Buy |
17,058
+5,398
| +46% | +$2.9M | 1.15% | 17 |
|
|
2023
Q2 | $5.47M | Buy |
11,660
+752
| +7% | +$353K | 0.67% | 32 |
|
|
2023
Q1 | $3.75M | Buy |
10,908
+2,725
| +33% | +$936K | 0.54% | 37 |
|
|
2022
Q4 | $2.99M | Buy |
8,183
+6,004
| +276% | +$2.2M | 0.42% | 39 |
|
|
2022
Q3 | $704K | Buy |
2,179
+793
| +57% | +$256K | 0.13% | 81 |
|
|
2022
Q2 | $449K | Sell |
1,386
-25
| -2% | -$8.1K | 0.08% | 99 |
|
|
2022
Q1 | $404K | Buy |
1,411
+161
| +13% | +$46.1K | 0.05% | 122 |
|
|
2021
Q4 | $345K | Buy |
1,250
+50
| +4% | +$13.8K | 0.04% | 144 |
|
|
2021
Q3 | $277K | Buy |
+1,200
| New | +$277K | 0.04% | 144 |
|
|
2015
Q2 | – | Sell |
-8,331
| Closed | -$605K | – | 146 |
|
|
2015
Q1 | $605K | Buy |
8,331
+2
| +0% | +$145 | 0.58% | 35 |
|
|
2014
Q4 | $574K | Buy |
+8,329
| New | +$574K | 0.67% | 31 |
|